drugset / Trial / NCT00287781

A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

NCT00287781 ↗

Completed 150 enrolled Kern Medical Center
RandomizedSingle-groupDouble-blindTreatment

Summary

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

Timeline

Start
2002-01
Primary completion
—
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — Intranasal

Indications